It is truly remarkable that patients whose HIV is controlled on antiviral therapy will have a life-expectation similar to that of the general population. However, little research has been done on what the quality of this life might be. In The Lancet HIV, Alec Miners and colleagues1 research health related quality of life (HRQoL) of people with HIV in the era of combination ART. The authors point out that HIV positive people doing well on treatment have a significantly reduced HRQoL compared with that in the general population.
No takes yet. Share an insight, caveat, or question.
Anton Pozniak (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: